title: Hybrid peptides in the landscape of drug discovery.
authors.affiliation: LPCNO, ERL 1226 INSERM, Université de Toulouse, CNRS, INSA, UPS, 135 avenue de Rangueil, 31077 Toulouse, France. Electronic address: Daniel.Fourmy@inserm.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Fourmy
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D055808:Drug Discovery; D004967:Estrogens / Q000737:chemistry; D005934:Glucagon / Q000737:chemistry; D052216:Glucagon-Like Peptide 1 / Q000737:chemistry; D006801:Humans; D008024:Ligands; D023421:Models, Animal; D009765:Obesity / Q000628:therapy*; D036361:Peptide Hormones / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
chemical_list: D004967:Estrogens; D008024:Ligands; D036361:Peptide Hormones; D011993:Recombinant Fusion Proteins; D052216:Glucagon-Like Peptide 1; D005934:Glucagon